Pulmatrix Historical Balance Sheet

PULM Stock

USD 6.21 0.12 1.90%

Trend analysis of Pulmatrix balance sheet accounts such as Other Current Assets of 544.3 K, Other Stockholder Equity of 188 M, Total Assets of 9.4 M or Short Long Term Debt Total of 7.8 M provides information on Pulmatrix's total assets, liabilities, and equity, which is the actual value of Pulmatrix to its prevalent stockholders. By breaking down trends over time using Pulmatrix balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Pulmatrix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pulmatrix is a good buy for the upcoming year.

Pulmatrix Inventory

(404,225)

Build AI portfolio with Pulmatrix Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

About Pulmatrix Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Pulmatrix at a specified time, usually calculated after every quarter, six months, or one year. Pulmatrix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Pulmatrix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Pulmatrix currently owns. An asset can also be divided into two categories, current and non-current.

Pulmatrix Balance Sheet Chart

At this time, Pulmatrix's Net Tangible Assets are very stable compared to the past year. As of the 20th of July 2025, Intangible Assets is likely to grow to about 6.7 M, though Retained Earnings are likely to grow to (282.3 M).

Accounts Payable Common Stock Shares Outstanding Other Current Assets Total Assets

Add Fundamental

Accounts Payable

An accounting item on the balance sheet that represents Pulmatrix obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Pulmatrix are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Total Assets

Total assets refers to the total amount of Pulmatrix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pulmatrix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Pulmatrix's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Pulmatrix current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.At this time, Pulmatrix's Net Tangible Assets are very stable compared to the past year. As of the 20th of July 2025, Intangible Assets is likely to grow to about 6.7 M, though Retained Earnings are likely to grow to (282.3 M).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	857K	8.8M	7.9M	7.8M
Total Assets	41.0M	34.0M	9.9M	9.4M

Short Long Term Debt Total Total Assets

Pulmatrix balance sheet Correlations

	Other Current Liab	Total Stockholder Equity	Retained Earnings	Accounts Payable	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Other Current Liab		0.0	-0.35	0.26	0.18	0.22	0.38	0.1	-0.52	0.21	0.12	0.5	-0.34	-0.02	0.25	0.04	-0.02	0.1	0.1	-0.26	0.07	0.24	0.1	0.0	-0.52	0.24
Total Stockholder Equity	0.0		-0.46	0.51	0.36	0.74	0.58	0.93	-0.43	0.25	0.26	0.39	-0.82	0.91	0.36	0.63	0.91	0.01	-0.15	0.58	0.13	0.48	0.21	0.88	-0.39	0.45
Retained Earnings	-0.35	-0.46		-0.8	-0.82	-0.7	-0.97	-0.55	0.86	-0.42	-0.41	-0.88	0.74	-0.49	-0.25	-0.4	-0.49	-0.2	0.03	-0.13	0.06	-0.51	-0.37	-0.51	0.9	-0.93
Accounts Payable	0.26	0.51	-0.8		0.63	0.63	0.82	0.59	-0.68	0.25	0.71	0.7	-0.58	0.4	0.57	0.58	0.4	0.08	-0.01	0.44	-0.07	0.53	0.69	0.41	-0.76	0.68
Common Stock Shares Outstanding	0.18	0.36	-0.82	0.63		0.5	0.74	0.35	-0.46	0.03	0.45	0.5	-0.56	0.47	-0.16	0.44	0.47	0.02	-0.51	0.11	-0.43	0.21	0.44	0.46	-0.54	0.92
Other Current Assets	0.22	0.74	-0.7	0.63	0.5		0.75	0.84	-0.71	0.56	0.34	0.74	-0.75	0.69	0.5	0.43	0.69	0.32	0.02	0.44	0.05	0.73	0.3	0.72	-0.71	0.6
Other Stockholder Equity	0.38	0.58	-0.97	0.82	0.74	0.75		0.67	-0.87	0.48	0.45	0.88	-0.81	0.58	0.34	0.48	0.58	0.22	0.02	0.23	0.04	0.6	0.4	0.6	-0.89	0.87
Total Assets	0.1	0.93	-0.55	0.59	0.35	0.84	0.67		-0.57	0.56	0.39	0.57	-0.85	0.91	0.45	0.65	0.91	0.31	0.0	0.69	0.27	0.77	0.33	0.92	-0.52	0.47
Short Long Term Debt Total	-0.52	-0.43	0.86	-0.68	-0.46	-0.71	-0.87	-0.57		-0.58	-0.23	-0.98	0.65	-0.38	-0.5	-0.24	-0.38	-0.28	-0.3	0.01	-0.25	-0.61	-0.18	-0.42	0.98	-0.67
Total Current Liabilities	0.21	0.25	-0.42	0.25	0.03	0.56	0.48	0.56	-0.58		0.15	0.65	-0.52	0.42	0.26	0.12	0.42	0.85	0.51	0.37	0.6	0.89	0.09	0.51	-0.49	0.22
Property Plant And Equipment Net	0.12	0.26	-0.41	0.71	0.45	0.34	0.45	0.39	-0.23	0.15		0.28	-0.25	0.28	0.34	0.8	0.28	0.08	-0.2	0.57	-0.23	0.48	0.99	0.28	-0.31	0.38
Current Deferred Revenue	0.5	0.39	-0.88	0.7	0.5	0.74	0.88	0.57	-0.98	0.65	0.28		-0.65	0.37	0.49	0.24	0.37	0.39	0.29	0.06	0.19	0.69	0.24	0.42	-0.98	0.69
Net Debt	-0.34	-0.82	0.74	-0.58	-0.56	-0.75	-0.81	-0.85	0.65	-0.52	-0.25	-0.65		-0.86	-0.2	-0.5	-0.86	-0.27	0.05	-0.45	-0.21	-0.62	-0.18	-0.86	0.61	-0.71
Cash	-0.02	0.91	-0.49	0.4	0.47	0.69	0.58	0.91	-0.38	0.42	0.28	0.37	-0.86		0.05	0.63	1.0	0.23	-0.27	0.61	0.21	0.59	0.21	0.99	-0.31	0.53
Non Current Assets Total	0.25	0.36	-0.25	0.57	-0.16	0.5	0.34	0.45	-0.5	0.26	0.34	0.49	-0.2	0.05		0.24	0.05	0.02	0.47	0.34	0.12	0.45	0.33	0.06	-0.53	-0.01
Non Currrent Assets Other	0.04	0.63	-0.4	0.58	0.44	0.43	0.48	0.65	-0.24	0.12	0.8	0.24	-0.5	0.63	0.24		0.63	0.01	-0.24	0.6	-0.19	0.44	0.79	0.62	-0.26	0.39
Cash And Short Term Investments	-0.02	0.91	-0.49	0.4	0.47	0.69	0.58	0.91	-0.38	0.42	0.28	0.37	-0.86	1.0	0.05	0.63		0.23	-0.27	0.61	0.21	0.59	0.21	0.99	-0.31	0.53
Net Receivables	0.1	0.01	-0.2	0.08	0.02	0.32	0.22	0.31	-0.28	0.85	0.08	0.39	-0.27	0.23	0.02	0.01	0.23		0.43	0.33	0.4	0.73	0.08	0.34	-0.22	0.03
Common Stock Total Equity	0.1	-0.15	0.03	-0.01	-0.51	0.02	0.02	0.0	-0.3	0.51	-0.2	0.29	0.05	-0.27	0.47	-0.24	-0.27	0.43		-0.06	0.48	0.27	-0.18	-0.21	-0.23	-0.31
Non Current Liabilities Total	-0.26	0.58	-0.13	0.44	0.11	0.44	0.23	0.69	0.01	0.37	0.57	0.06	-0.45	0.61	0.34	0.6	0.61	0.33	-0.06		0.13	0.63	0.54	0.62	0.0	0.09
Inventory	0.07	0.13	0.06	-0.07	-0.43	0.05	0.04	0.27	-0.25	0.6	-0.23	0.19	-0.21	0.21	0.12	-0.19	0.21	0.4	0.48	0.13		0.43	-0.32	0.25	-0.08	-0.18
Total Liab	0.24	0.48	-0.51	0.53	0.21	0.73	0.6	0.77	-0.61	0.89	0.48	0.69	-0.62	0.59	0.45	0.44	0.59	0.73	0.27	0.63	0.43		0.42	0.66	-0.57	0.33
Property Plant And Equipment Gross	0.1	0.21	-0.37	0.69	0.44	0.3	0.4	0.33	-0.18	0.09	0.99	0.24	-0.18	0.21	0.33	0.79	0.21	0.08	-0.18	0.54	-0.32	0.42		0.22	-0.27	0.32
Total Current Assets	0.0	0.88	-0.51	0.41	0.46	0.72	0.6	0.92	-0.42	0.51	0.28	0.42	-0.86	0.99	0.06	0.62	0.99	0.34	-0.21	0.62	0.25	0.66	0.22		-0.35	0.53
Short Term Debt	-0.52	-0.39	0.9	-0.76	-0.54	-0.71	-0.89	-0.52	0.98	-0.49	-0.31	-0.98	0.61	-0.31	-0.53	-0.26	-0.31	-0.22	-0.23	0.0	-0.08	-0.57	-0.27	-0.35		-0.72
Common Stock	0.24	0.45	-0.93	0.68	0.92	0.6	0.87	0.47	-0.67	0.22	0.38	0.69	-0.71	0.53	-0.01	0.39	0.53	0.03	-0.31	0.09	-0.18	0.33	0.32	0.53	-0.72

Click cells to compare fundamentals

Pulmatrix Account Relationship Matchups

Pulmatrix balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Current Liab	1.8M	893K	(198K)	781K	120K	126K
Total Stockholder Equity	23.1M	47.4M	31.1M	18.0M	8.9M	8.5M
Retained Earnings	(234.5M)	(254.6M)	(273.5M)	(287.6M)	(297.2M)	(282.3M)
Accounts Payable	851K	839K	1.2M	1.9M	809K	847.6K
Common Stock Shares Outstanding	1.4M	2.7M	3.4M	3.7M	3.7M	3.8M
Other Current Assets	723K	871K	1.1M	742K	399K	544.3K
Other Stockholder Equity	257.6M	301.0M	304.6M	305.6M	306.1M	188.0M
Total Assets	38.2M	58.8M	41.0M	34.0M	9.9M	9.4M
Short Long Term Debt Total	1.7M	2.3M	857K	8.8M	7.9M	7.8M
Total Current Liabilities	8.3M	4.4M	5.0M	3.9M	929K	882.6K
Property Plant And Equipment Net	900K	1.9M	2.4M	945K	11.5M	0.0
Current Deferred Revenue	4.2M	939K	1.3M	618K	710.7K	746.2K
Net Debt	(29.9M)	(51.6M)	(34.8M)	(10.4M)	(9.5M)	(10.0M)
Cash	31.7M	53.8M	35.6M	19.2M	9.5M	9.0M
Non Current Assets Total	5.6M	4.0M	2.8M	13.1M	23K	21.9K
Cash And Short Term Investments	31.7M	53.8M	35.6M	19.2M	9.5M	9.0M
Net Receivables	0.0	7.2M	84K	67K	1.3M	928K
Liabilities And Stockholders Equity	38.2M	58.8M	41.0M	34.0M	9.9M	9.4M
Non Current Liabilities Total	6.8M	6.9M	4.8M	12.1M	67K	63.7K
Total Liab	15.0M	11.4M	9.8M	16.0M	996K	946.2K
Property Plant And Equipment Gross	900K	361.0	2.4M	945K	13.2M	0.0
Total Current Assets	32.5M	54.8M	38.1M	20.8M	9.9M	9.4M
Short Term Debt	2.3M	2.9M	1.7M	429K	386.1K	366.8K
Net Tangible Assets	7.4M	19.6M	46.4M	31.1M	35.8M	37.6M
Other Assets	1.7K	1.6M	1.9M	1.0	1.15	1.09
Property Plant Equipment	270K	1.9M	2.4M	945K	1.1M	991.8K
Net Invested Capital	23.1M	46.4M	31.1M	18.0M	8.9M	8.5M
Net Working Capital	24.3M	50.3M	33.1M	16.9M	9.0M	8.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:

How To Invest In Pulmatrix

Details

Is Pulmatrix Stock a good investment?

Details

What is Pulmatrix's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.35)

Revenue Per Share

0.526

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.32)

Return On Equity

(0.93)

The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Pulmatrix Historical Balance Sheet

Pulmatrix Inventory

(404,225)

About Pulmatrix Balance Sheet Analysis

Pulmatrix Balance Sheet Chart

Accounts Payable

Common Stock Shares Outstanding

Other Current Assets

Total Assets

Pulmatrix balance sheet Correlations

Pulmatrix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pulmatrix balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Short Term Debt	+ 0.98	Short Long Term Debt Total
Total Assets	+ 0.93	Total Stockholder Equity

Short Term Debt	- 0.98	Current Deferred Revenue
Current Deferred Revenue	- 0.98	Short Long Term Debt Total
Other Stockholder Equity	- 0.97	Retained Earnings
Common Stock	- 0.93	Retained Earnings
Short Term Debt	- 0.89	Other Stockholder Equity
Current Deferred Revenue	- 0.88	Retained Earnings